Novartis Joins MRGPRX2 Race Through $800m+ Kyorin Deal

Addition To CSU Portfolio

 
• By Lisa Takagi
  
Kyorin Novartis deal
$800m deal with Kyorin has brought another CSU candidate to Novartis. (Shutterstock)

More from Deals

More from Therapy Areas